Dimerization propensity of the β <sub>1</sub> -adrenergic receptor in lipid nanodiscs probed by DEER and single-molecule spectroscopies
Abstract
G protein–coupled receptors (GPCRs) comprise a large class of membrane proteins that mediate cellular responses to a wide range of external signals and as such constitute major drug targets. While oligomerization has been shown to play a well-established role in modulating signaling for class C GPCRs (e.g., the glutamate and GABA receptors), the functional relevance of oligomerization for class A receptors, such as the β 1 -adrenergic receptor (β 1 AR), remains unclear. Here, we have examined the influence of the membrane mimetic environment on the dimerization propensity of β 1 AR using a combination of pulsed Q-band double electron–electron resonance spectroscopy and single-molecule fluorescence brightness measurements in an Anti-Brownian Elektrokinetic trap. While β 1 AR is predominantly monomeric in docecyl-β-D-maltoside (DDM) micelles, reconstitution of β 1 AR in lipid nanodiscs preferentially favors symmetric parallel dimers. Using nanodiscs of different diameters we observed a clear size-dependent increase in the dimer fraction, reaching over 50% of the β 1 AR molecules in large (~12.5 nm diameter) nanodiscs. Addition of cholesteryl hemisuccinate, an analog of cholesterol, suppresses β 1 AR dimerization in lipid nanodiscs, recapitulating the behavior in DDM micelles. This work provides quantitative evidence that β 1 AR possesses an intrinsic, membrane sensitive predisposition for dimerization, and highlights the importance of spatial membrane constraints in the modulation of class A GPCR dimerization.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (4)
Nina Kubatova
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Thomas Schmidt
Quan Wang
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases
G. Marius Clore
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health